123 related articles for article (PubMed ID: 21404592)
1. [Molecular mechanism of the acquisition of new-quinolone resistance in Mycobacterium leprae and M. tuberculosis and rapid differentiation methods for resistant bacilli].
Kim H; Suzuki H; Matsuoka M; Matsuba T; Yokoyama K; Nakajima C; Suzuki Y
Nihon Hansenbyo Gakkai Zasshi; 2011 Feb; 80(1):17-27. PubMed ID: 21404592
[TBL] [Abstract][Full Text] [Related]
2. Amino acid substitutions at position 95 in GyrA can add fluoroquinolone resistance to Mycobacterium leprae.
Yokoyama K; Kim H; Mukai T; Matsuoka M; Nakajima C; Suzuki Y
Antimicrob Agents Chemother; 2012 Feb; 56(2):697-702. PubMed ID: 22106221
[TBL] [Abstract][Full Text] [Related]
3. Interaction of Quinolones Carrying New R1 Group with
Park JH; Yamaguchi T; Ouchi Y; Koide K; Pachanon R; Chizimu JY; Mori S; Kim H; Mukai T; Nakajima C; Suzuki Y
Microb Drug Resist; 2021 Dec; 27(12):1616-1623. PubMed ID: 34077282
[No Abstract] [Full Text] [Related]
4. Determination of the primary target of a quinolone drug and the effect of quinolone resistance-conferring mutations by measuring quinolone sensitivity based on its mode of action.
Pfeiffer ES; Hiasa H
Antimicrob Agents Chemother; 2007 Sep; 51(9):3410-2. PubMed ID: 17606687
[TBL] [Abstract][Full Text] [Related]
5. [What Hansen's disease research learned from tuberculosis research: from molecular biological aspect].
Suzuki Y; Yamaguchi T; Kim H; Yokoyama K; Nakajima C
Nihon Hansenbyo Gakkai Zasshi; 2014 Dec; 83(3):21-7. PubMed ID: 25826852
[TBL] [Abstract][Full Text] [Related]
6. In vitro antituberculosis activities of ACH-702, a novel isothiazoloquinolone, against quinolone-susceptible and quinolone-resistant isolates.
Pucci MJ; Ackerman M; Thanassi JA; Shoen CM; Cynamon MH
Antimicrob Agents Chemother; 2010 Aug; 54(8):3478-80. PubMed ID: 20516287
[TBL] [Abstract][Full Text] [Related]
7. Quinolone resistance-associated amino acid substitutions affect enzymatic activity of Mycobacterium leprae DNA gyrase.
Yamaguchi T; Yokoyama K; Nakajima C; Suzuki Y
Biosci Biotechnol Biochem; 2017 Jul; 81(7):1343-1347. PubMed ID: 28417702
[TBL] [Abstract][Full Text] [Related]
8. Novel gyrase mutations in quinolone-resistant and -hypersusceptible clinical isolates of Mycobacterium tuberculosis: functional analysis of mutant enzymes.
Aubry A; Veziris N; Cambau E; Truffot-Pernot C; Jarlier V; Fisher LM
Antimicrob Agents Chemother; 2006 Jan; 50(1):104-12. PubMed ID: 16377674
[TBL] [Abstract][Full Text] [Related]
9. Are all the DNA gyrase mutations found in Mycobacterium leprae clinical strains involved in resistance to fluoroquinolones?
Matrat S; Cambau E; Jarlier V; Aubry A
Antimicrob Agents Chemother; 2008 Feb; 52(2):745-7. PubMed ID: 18070975
[TBL] [Abstract][Full Text] [Related]
10. Quinolone resistance mechanisms in pneumococci.
Eliopoulos GM
Clin Infect Dis; 2004 May; 38 Suppl 4():S350-6. PubMed ID: 15127369
[TBL] [Abstract][Full Text] [Related]
11. Drug resistance in leprosy.
Matsuoka M
Jpn J Infect Dis; 2010 Jan; 63(1):1-7. PubMed ID: 20093754
[TBL] [Abstract][Full Text] [Related]
12. [Novel method for simple detection of mutations conferring drug resistance in Mycobacterium leprae, based on a DNA microarray, and its applicability in developing countries].
Matsuoka M; Suzuki Y; Makino M
Nihon Hansenbyo Gakkai Zasshi; 2010 Sep; 79(3):257-61. PubMed ID: 20857655
[TBL] [Abstract][Full Text] [Related]
13. Fluoroquinolone resistance linked to both gyrA and parC mutations in the quinolone resistance-determining region of Shigella dysenteriae type 1.
Talukder KA; Khajanchi BK; Islam MA; Islam Z; Dutta DK; Rahman M; Watanabe H; Nair GB; Sack DA
Curr Microbiol; 2006 Feb; 52(2):108-11. PubMed ID: 16450072
[TBL] [Abstract][Full Text] [Related]
14. Role of gyrB Mutations in Pre-extensively and Extensively Drug-Resistant Tuberculosis in Thai Clinical Isolates.
Disratthakit A; Prammananan T; Tribuddharat C; Thaipisuttikul I; Doi N; Leechawengwongs M; Chaiprasert A
Antimicrob Agents Chemother; 2016 Sep; 60(9):5189-97. PubMed ID: 27297489
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of gatifloxacin derivatives and their biological activities against Mycobacterium leprae and Mycobacterium tuberculosis.
Gomez C; Ponien P; Serradji N; Lamouri A; Pantel A; Capton E; Jarlier V; Anquetin G; Aubry A
Bioorg Med Chem; 2013 Feb; 21(4):948-56. PubMed ID: 23294829
[TBL] [Abstract][Full Text] [Related]
16. Impact of amino acid substitutions in B subunit of DNA gyrase in Mycobacterium leprae on fluoroquinolone resistance.
Yokoyama K; Kim H; Mukai T; Matsuoka M; Nakajima C; Suzuki Y
PLoS Negl Trop Dis; 2012; 6(10):e1838. PubMed ID: 23071850
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Ofloxacin Interaction with Mutated (A91V) Quinolone Resistance Determining Region of DNA Gyrase in Mycobacterium Leprae through Computational Simulation.
Nisha J; Shanthi V
Cell Biochem Biophys; 2018 Jun; 76(1-2):125-134. PubMed ID: 28822069
[TBL] [Abstract][Full Text] [Related]
18. Structural insights into the quinolone resistance mechanism of Mycobacterium tuberculosis DNA gyrase.
Piton J; Petrella S; Delarue M; André-Leroux G; Jarlier V; Aubry A; Mayer C
PLoS One; 2010 Aug; 5(8):e12245. PubMed ID: 20805881
[TBL] [Abstract][Full Text] [Related]
19. Apigenin as an anti-quinolone-resistance antibiotic.
Morimoto Y; Baba T; Sasaki T; Hiramatsu K
Int J Antimicrob Agents; 2015 Dec; 46(6):666-73. PubMed ID: 26526895
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of drug resistance: quinolone resistance.
Hooper DC; Jacoby GA
Ann N Y Acad Sci; 2015 Sep; 1354(1):12-31. PubMed ID: 26190223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
